Cristina Csimma
CIK 1501623 · last filed 2024-02-13
Cristina Csimma is a corporate insider who has filed 21 SEC Form 4 insider transactions across 6 companies since 2011. The most recent filing, for PALI, was dated Feb 13, 2024. Current disclosed insider exposure totals $1.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.7K
6
21
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PALI | Director | 857 | $2.02 | $1.7K | $0 | 4 | 2024-02-13 |
| Aceragen, Inc. (IDRA) Delisted | Director | — | $7.22 | — | $0 | 5 | 2022-06-27 |
| PALISADE BIO, INC. (SNCA) Delisted | Director | — | $9.96 | — | $0 | 2 | 2021-04-26 |
| PALISADE BIO, INC. (CUR) Delisted | Director | — | — | — | $0 | 3 | 2019-10-11 |
| JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Director | 0 | — | — | $0 | 4 | 2018-08-15 |
| JUNIPER PHARMACEUTICALS INC (CBRX) Delisted | Director | 129,261 | — | — | $0 | 3 | 2013-05-03 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-13 | PALI | Exer (M) | +12,800 | $0 | EDGAR |
| 2023-11-24 | PALI | Grant (A) | — | $0 | EDGAR |
| 2023-06-13 | PALI | Grant (A) | — | $0 | EDGAR |
| 2022-06-27 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-10 | PALI | Grant (A) | — | $0 | EDGAR |
| 2021-06-10 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-26 | PALISADE BIO, INC. (SNCA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-19 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-07 | PALISADE BIO, INC. (SNCA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-10-11 | PALISADE BIO, INC. (CUR) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.